pharma research

Researchers have only been able to get around 70 per cent of the patients needed for the trials

Nafamostat is identified as a potential candidate for COVID-19 patients by scientists at the University of Tokyo and Leibniz…

The findings show that at a concentration of 50 micromolar (μM) of Celecoxib or Carprofen, the inhibition of the in vitro activity…

The investigators have already performed the in silico work by high-throughput virtual screening approach to examine the binding…

The researchers speculate that the greater degree of clot formation and blood vessel generation in COVID-19 patients may have…

The new technique involving the use of inert oils to control evaporative solvent loss can unlock the potential of accelerated new…

The Indian government has also initiated a study on whether Ashwagandha can be an alternative to hydroxychloroquine as a potential…

Reportedly, the medical team is preparing a paper on the development of the drug combination for an international journal, as…

69.9 per cent of disruptions due to the suspension of enrolment, informs a GlobalData study

Calls on scientists and researchers to create a centralised platform and work together to develop and actualise a cancer research…